FATTY ACID AND PEPTIDE AMIDATION--A SHARED MECHANSIM
脂肪酸和肽酰胺化——共享机制
基本信息
- 批准号:6639546
- 负责人:
- 金额:$ 22.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adenoviridae amidation /deamidation antisense nucleic acid brain metabolism cell differentiation cell free system cell line disulfiram enzyme activity fatty acid metabolism isozymes laboratory rat neuroblastoma neurogenesis neuropharmacology oxygenases peptides protein metabolism radioimmunoassay transfection /expression vector
项目摘要
DESCRIPTION: (Adapted from Applicant's Abstract ) Sleep is ubiquitous among
mammals and essential for life. More than seventy types of sleep disorders
chronically affect millions of Americans in all age groups. Recently, it was
shown that the primary fatty-acid amide, oleamide, is a mediator of sleep and
may thus contribute to the genesis of sleep disorders. Oleamide accumulates in
cerebral spinal fluid during sleep deprivation and induces profound motor
quiescence and a sleep-like state upon administration. Primary fatty-acid
amides represent a new class of receptor-active signaling molecules whose
biogenesis is unknown. Understanding the pathway involved will offer targets
for the therapeutic interventions for treating sleep disorders. Recently, we
established in vitro that peptidylglycine-alpha-amidating monooxygenase (PAM;
EC 1.14.17.3) is able to catalyze the formation of oleamide. PAM is known for
its role as the rate-limiting enzyme in the production of peptide messengers
and may thus regulate the production of primary fatty-acid amides as well. The
objective of this research is to elucidate the mechanisms that govern oleamide
production in brain. Three specific aims are proposed for testing the
hypothesis that PAM is the physiologic mediator of oleamide biosynthesis. Aim
1. Establish in a cell-free system that oleamide biosynthesis is dependent upon
the actions of PAM. Cell-free models permit the direct investigation of
fundamental reaction components. Subcellular fractions of N18TG2 mouse
neuroblastoma cells, a line which expresses PAM and synthesizes oleamide, will
be used to determine the effects of PAM inhibition on the biosynthesis of
oleamide. Aim 2. Establish in cell culture that the induction of PAM during
neuronal differentiation mediates an increase in oleamide production. Antisense
RNA inhibition of PAM expression will be used to directly establish PAM as an
integral component of the oleamide biosynthesis pathway in whole cells. Aim 3.
Establish that the production of oleamide in vivo is dependent upon the action
of PAM. Experiments conducted in rats will take into account the full biologic
complexity of the mammalian organism. Direct measures of oleamide in brain and
assessments of tissue activity for oleamide biosynthetic labeling will be used
to demonstrate the extent to which inhibition of PAM in vivo impairs oleamide
biosynthesis. These studies will define the physiologic role of PAM in
mediating the biosynthesis of oleamide. Demonstrating that oleamide
biosynthesis proceeds through PAM, or via an alternative pathway, will provide
a basis for improving the diagnosis and treatment of sleep disorders.
描述:(根据申请者摘要改编)睡眠普遍存在于
哺乳动物和生命的必需品。70多种睡眠障碍
长期影响着所有年龄段的数百万美国人。最近,它是
研究表明,主要的脂肪酸酰胺,油酰胺,是睡眠和
可能因此导致睡眠障碍的发生。油酰胺在体内积聚
睡眠剥夺时的脑脊液和深部运动
服药后处于静止状态和睡眠状态。初级脂肪酸
酰胺类代表了一类新的受体活性信号分子,其
生物发生尚不清楚。了解所涉及的途径将提供靶点
用于治疗睡眠障碍的治疗干预。最近,我们
在体外建立了肽甘氨酸-α-酰胺化单加氧酶(PAM;
EC 1.14.17.3)能够催化油酰胺的形成。帕姆以
它在多肽信使生产中作为限速酶的作用
并因此也可以调节初级脂肪酸酰胺的产生。这个
本研究的目的是阐明油酰胺的调控机制。
大脑中的生产。提出了三个具体目标来测试
假设PAM是油酰胺生物合成的生理介体。目标
1.在无细胞体系中建立油酰胺生物合成依赖于
PAM的作用。无细胞模型允许直接调查
基本反应组件。N18TG2小鼠亚细胞组分的研究
神经母细胞瘤细胞,一种表达PAM和合成油酰胺的细胞,将
用来测定PAM抑制对生物合成的影响
油酰胺。目的2.在细胞培养中建立PAM的诱导
神经元分化介导了油酰胺产量的增加。反义
RNA抑制PAM的表达将用于直接建立PAM作为一种
整个细胞中油酰胺生物合成途径的组成部分。目标3.
证实体内油酰胺的产生依赖于这种作用
PAM。在老鼠身上进行的实验将考虑到完整的生物学
哺乳动物有机体的复杂性。脑组织和脑组织中油酰胺的直接测量
将使用油酰胺生物合成标记的组织活性评估
为了证明体内PAM抑制对油酰胺的损害程度
生物合成。这些研究将确定PAM在体内的生理作用
调节油酰胺的生物合成。证明油酰胺
生物合成通过PAM进行,或通过替代途径,将提供
为提高睡眠障碍的诊断和治疗水平奠定了基础。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Murine atrial HL-1 cells express highly active peptidylglycine alpha-amidating enzyme.
小鼠心房 HL-1 细胞表达高活性肽基甘氨酸 α-酰胺化酶。
- DOI:10.1016/j.peptides.2005.10.017
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Driscoll,WilliamJ;Hill,Diane;Smalstig,Alexi;Mueller,GregoryP
- 通讯作者:Mueller,GregoryP
In vitro synthesis of oleoylglycine by cytochrome c points to a novel pathway for the production of lipid signaling molecules.
细胞色素 c 体外合成油酰甘氨酸指出了一条生产脂质信号分子的新途径。
- DOI:10.1074/jbc.m701801200
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Mueller,GregoryP;Driscoll,WilliamJ
- 通讯作者:Driscoll,WilliamJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY P MUELLER其他文献
GREGORY P MUELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY P MUELLER', 18)}}的其他基金
FATTY ACID AND PEPTIDE AMIDATION--A SHARED MECHANSIM
脂肪酸和肽酰胺化——共享机制
- 批准号:
6540029 - 财政年份:2000
- 资助金额:
$ 22.28万 - 项目类别:
FATTY ACID AND PEPTIDE AMIDATION--A SHARED MECHANSIM
脂肪酸和肽酰胺化——共享机制
- 批准号:
6394028 - 财政年份:2000
- 资助金额:
$ 22.28万 - 项目类别:
FATTY ACID AND PEPTIDE AMIDATION--A SHARED MECHANSIM
脂肪酸和肽酰胺化——共享机制
- 批准号:
6097015 - 财政年份:2000
- 资助金额:
$ 22.28万 - 项目类别:
PEPTIDE ALPHA AMIDATION--MECHANISMS FOR REGULATION
肽α酰胺化——调节机制
- 批准号:
2431276 - 财政年份:1995
- 资助金额:
$ 22.28万 - 项目类别:
PEPTIDE ALPHA AMIDATION--MECHANISMS FOR REGULATION
肽α酰胺化——调节机制
- 批准号:
2273317 - 财政年份:1995
- 资助金额:
$ 22.28万 - 项目类别:
PEPTIDE ALPHA AMIDATION--MECHANISMS FOR REGULATION
肽α酰胺化——调节机制
- 批准号:
2273316 - 财政年份:1995
- 资助金额:
$ 22.28万 - 项目类别:
NEUROTRANSMITTER REGULATION OF BETA-ENDORPHIN SECRETION
神经递质对 β-内啡肽分泌的调节
- 批准号:
3449647 - 财政年份:1983
- 资助金额:
$ 22.28万 - 项目类别:














{{item.name}}会员




